Physician profile
John Patrick Gallagher
NPI 1649908971
$3,400.74
in general payments reported to CMS, 2019-2025
10 companies · $1,881 in 2025
The $1,881 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $318 · 2023: $542 · 2024: $660 · 2025: $1,881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,932 · Travel and Lodging: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,931.90 |
| Travel and Lodging | $1,150.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,885.94 | 2023-2025 | Total30, Precision7, Clareon |
| Bausch & Lomb Americas INC. | $364.28 | 2022-2025 | Miebo, Xiidra, Infuse |
| Sun Pharmaceutical Industries INC. | $282.21 | 2022-2024 | Cequa |
| Amgen INC. | $244.79 | 2024 | Tepezza |
| Ocular Therapeutix, INC. | $190.23 | 2023-2024 | Dextenza |
| Apellis Pharmaceuticals, INC. | $125.00 | 2025 | Syfovre |
| Oyster Point Pharma, INC. | $117.58 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $109.28 | 2024 | Tecnis Iol |
| Carl Zeiss Meditec, INC. | $66.00 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $15.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.